FDA Warning Letter — Zhejiang Bangli Medical Products Co., Ltd
The FDA took a Warning Letter action against Zhejiang Bangli Medical Products Co., Ltd on Jan 27, 2017 (Yongkang, China). The action was issued by CDER and concerns drugs products. This facility has 1 recent FDA inspection on record.
Action details
- Facility
- Zhejiang Bangli Medical Products Co., Ltd
- Date
- Jan 27, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Center
- CDER
- Location
- Yongkang (China)